Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 5849-5852, October 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harlow, B. L.
Right arrow Articles by Daling, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harlow, B. L.
Right arrow Articles by Daling, J. R.

Case-Control Study of Borderline Ovarian Tumors: Reproductive History and Exposure to Exogenous Female Hormones

Bernard L. Harlow1, Noel S. Weiss, Gilbert J. Roth, Joseph Chu and Janet R. Daling

Department of Epidemiology, School of Public Health and Community Medicine [B. L. H., N. S. W., J. C., J. R. D.] and Department of Pathology, School of Medicine [G. J. R.], University of Washington, Seattle 98195; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center [B. L. H., N. S. W., J. C., J. R. D.]; Laboratory of Pathology of Seattle [G. J. R.], Seattle, Washington 98104; and Obstetrics and Gynecology Epidemiology Center, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115 [B. L. H.]

Borderline ovarian tumors possess many of the same morphological features as their malignant counterparts, but they do not destructively invade the ovarian stroma, and the women in whom they develop generally have a favorable prognosis. Female residents of three urban counties of western Washington diagnosed with serous and mucinous borderline ovarian tumors between 1980 and 1985 (n = 116) were interviewed regarding past reproductive events. A random sample of women from the same counties (n = 158) was identified through random digit dialing and were interviewed. The risk of these ovarian tumors among women who had given birth to 1 or 2 children and to 3 or more children was, respectively, 0.7 and 0.4 that of nulliparous women. There was no consistent influence of increasing age at first live birth. Adjusting for parity, a history of lactation was associated with a 50% reduction in risk. Among nulliparous women, a further increase in risk was present in those who reported a history of infertility. Use of oral contraceptives was associated with a 60% reduction in risk. However, the size of the association was not dependent on duration, age at first use, or years since last usage. In conclusion, borderline tumors appear to have similar epidemiological patterns with regard to reproductive events as their more malignant counterparts.

1 To whom requests for reprints should be addressed, at Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, 221 Longwood Ave., Boston, MA 02115.

Received 3/14/88. Revised 6/10/88. Accepted 7/20/88.




This article has been cited by other articles:


Home page
Hum ReprodHome page
C. Basille, F. Olivennes, J. Le Calvez, N. Beron-Gaillard, G. Meduri, C. Lhomme, P. Duvillard, J. Benard, and P. Morice
Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours
Hum. Reprod., December 1, 2006; 21(12): 3241 - 3245.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. L. Gierach, F. Modugno, and R. B. Ness
Relations of Gestational Length and Timing and Type of Incomplete Pregnancy to Ovarian Cancer Risk
Am. J. Epidemiol., March 1, 2005; 161(5): 452 - 461.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
F. Modugno
Ovarian Cancer and Polymorphisms in the Androgen and Progesterone Receptor Genes: A HuGE Review
Am. J. Epidemiol., February 15, 2004; 159(4): 319 - 335.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. Riman, P. W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, C. M. Magnusson, E. Weiderpass, and I. R. Persson
Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish Women
J Natl Cancer Inst, April 3, 2002; 94(7): 497 - 504.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. Rodriguez, A. V. Patel, E. E. Calle, E. J. Jacob, and M. J. Thun
Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US Women
JAMA, March 21, 2001; 285(11): 1460 - 1465.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. B. Ness and C. Cottreau
Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
J Natl Cancer Inst, September 1, 1999; 91(17): 1459 - 1467.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.